Polak M - Search Results

1

Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy.

Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M. Rolon MA, et al. Among authors: polak m. Acta Paediatr. 2001 Aug;90(8):860-7. Acta Paediatr. 2001. PMID: 11529531

2

Successful off-label sulfonylurea treatment of neonatal diabetes mellitus due to chromosome 6 abnormalities.

Garcin L, Kariyawasam D, Busiah K, Fauret-Amsellem AL, Le Bourgeois F, Vaivre-Douret L, Cavé H, Polak M, Beltrand J. Garcin L, et al. Among authors: polak m. Pediatr Diabetes. 2018 Jun;19(4):663-669. doi: 10.1111/pedi.12635. Epub 2018 Mar 4. Pediatr Diabetes. 2018. PMID: 29504184 Review.

3

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.

Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, Flanagan SE, Babiker T, Thomas NJ, Shepherd MH, Ellard S, Klimes I, Szopa M, Polak M, Iafusco D, Hattersley AT, Njølstad PR; Neonatal Diabetes International Collaborative Group. Bowman P, et al. Among authors: polak m. Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646. doi: 10.1016/S2213-8587(18)30106-2. Epub 2018 Jun 4. Lancet Diabetes Endocrinol. 2018. PMID: 29880308 Free PMC article.

4

Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.

Beltrand J, Elie C, Busiah K, Fournier E, Boddaert N, Bahi-Buisson N, Vera M, Bui-Quoc E, Ingster-Moati I, Berdugo M, Simon A, Gozalo C, Djerada Z, Flechtner I, Treluyer JM, Scharfmann R, Cavé H, Vaivre-Douret L, Polak M; GlidKir Study Group. Beltrand J, et al. Among authors: polak m. Diabetes Care. 2015 Nov;38(11):2033-41. doi: 10.2337/dc15-0837. Epub 2015 Oct 5. Diabetes Care. 2015. PMID: 26438614 Clinical Trial.

5

Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations.

Riveline JP, Rousseau E, Reznik Y, Fetita S, Philippe J, Dechaume A, Hartemann A, Polak M, Petit C, Charpentier G, Gautier JF, Froguel P, Vaxillaire M. Riveline JP, et al. Among authors: polak m. Diabetes Care. 2012 Feb;35(2):248-51. doi: 10.2337/dc11-1469. Epub 2011 Dec 30. Diabetes Care. 2012. PMID: 22210575 Free PMC article.

6

Neonatal diabetes mellitus: a disease linked to multiple mechanisms.

Polak M, Cavé H. Polak M, et al. Orphanet J Rare Dis. 2007 Mar 9;2:12. doi: 10.1186/1750-1172-2-12. Orphanet J Rare Dis. 2007. PMID: 17349054 Free PMC article. Review.

7

Neonatal Diabetes Mellitus -- genetic aspects 2004.

Polak M, Shield J. Polak M, et al. Pediatr Endocrinol Rev. 2004 Dec;2(2):193-8. Pediatr Endocrinol Rev. 2004. PMID: 16429105 Review.

8

beta Cell autoimmunity in a child with M.O.D.Y. (Maturity Onset Diabetes in the Young).

Ortega-Rodriguez E, Levy-Marchal C, Guillermine S, Polak M. Ortega-Rodriguez E, et al. Among authors: polak m. Diabetes Metab. 2001 Feb;27(1):59-61. Diabetes Metab. 2001. PMID: 11240447

9

An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission.

Shield JP, Temple IK, Sabin M, Mackay D, Robinson DO, Betts PR, Carson DJ, Cavé H, Chevenne D, Polak M. Shield JP, et al. Among authors: polak m. Arch Dis Child Fetal Neonatal Ed. 2004 Jul;89(4):F341-3. doi: 10.1136/adc.2003.030502. Arch Dis Child Fetal Neonatal Ed. 2004. PMID: 15210671 Free PMC article.

10

[Early onset diabetes mellitus].

Busiah K, Vaivre-Douret L, Yachi C, Cavé H, Polak M. Busiah K, et al. Among authors: polak m. Arch Pediatr. 2013 Dec;20 Suppl 4:S117-26. doi: 10.1016/S0929-693X(13)71425-8. Arch Pediatr. 2013. PMID: 24360362 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results